GSK Nucala wins USFDA approval for two new self-administration options Farhat Nasim9 Jun 2019 10:00 AM ISTNucala is the first anti-IL5 biologic to be licensed in the US for at-home administration, and the first respiratory biologic to be approved for...
FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis Ruby Khatun Khatun15 Dec 2017 10:06 AM ISTThe U.S. Food and Drug Administration (FDA) expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis...